Literature DB >> 17413549

Home discharge experience with the Thoratec TLC-II portable driver.

Mark S Slaughter1, Michael A Sobieski, Michele Martin, Muhyaldeen Dia, Marc A Silver.   

Abstract

With the growing success and expanded use of ventricular assist devices, home discharge with independent ambulation and self-care are now important issues. We describe our initial home discharge experience with the Thoratec TLC-II portable drive. Patients discharged home were required to have five outpatient excursions (three monitored) before discharge and were seen weekly after discharge. Between August 2000 and December 2004, 14 patients (average age, 57 years) were placed on the TLC-II portable driver. One patient on the TLC-II portable driver had left ventricular assist device removal after 50 days of support but before discharge. Thirteen patients were discharged from the hospital with average time at home of 62 days (range, 16 to 243 days). After discharge, the TLC-II portable driver was maintained in the auto mode at average settings of 78 beat rate, 5.1 L/min flow rate, 204 mm Hg ejection pressure, and -8.4 mm Hg fill vacuum. A total of 5852 alarms (average, 6.7 per day) were recorded with 2373 battery reminders (41%), 1922 occlusion alarms during sleep (33%), and 1461 no-fill signals (25%). There were no readmissions for device malfunction, emergency battery utilization or back-up unit use. These results demonstrate that the Thoratec TLC-II portable driver is safe, reliable, and can be effectively managed at home.

Entities:  

Mesh:

Year:  2007        PMID: 17413549     DOI: 10.1097/MAT.0b013e31802c189e

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

Review 1.  Current status of extracorporeal ventricular assist devices in Japan.

Authors:  Takashi Nishimura
Journal:  J Artif Organs       Date:  2014-06-22       Impact factor: 1.731

2.  Development of a compact wearable pneumatic drive unit for a ventricular assist device.

Authors:  Akihiko Homma; Yoshiyuki Taenaka; Eisuke Tatsumi; Eiki Akagawa; Hwansung Lee; Tomohiro Nishinaka; Yoshiaki Takewa; Toshihide Mizuno; Tomonori Tsukiya; Yukihide Kakuta; Nobumasa Katagiri; Isao Shimosaki; Shigeru Hamada; Hiroshi Mukaibayashi; Wataru Iwaoka
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

3.  Fifteen-year experience with Toyobo paracorporeal left ventricular assist system.

Authors:  Shunsuke Saito; Goro Matsumiya; Taichi Sakaguchi; Tomoyuki Fujita; Toru Kuratani; Hajime Ichikawa; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2009-03-29       Impact factor: 1.731

Review 4.  Current state-of-the-art of device therapy for advanced heart failure.

Authors:  Lawrence S Lee; Prem S Shekar
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

5.  Home discharge and out-of-hospital follow-up of total artificial heart patients supported by a portable driver system.

Authors:  Aly El Banayosy; Lukacz Kizner; Latif Arusoglu; Michael Morshuis; Christof Brehm; Reiner Koerfer; Christoph Schuermann; Richard G Smith; Jack G Copeland; Marvin J Slepian
Journal:  ASAIO J       Date:  2014 Mar-Apr       Impact factor: 2.872

Review 6.  Mechanical circulatory assist devices: a primer for critical care and emergency physicians.

Authors:  Ayan Sen; Joel S Larson; Kianoush B Kashani; Stacy L Libricz; Bhavesh M Patel; Pramod K Guru; Cory M Alwardt; Octavio Pajaro; J Christopher Farmer
Journal:  Crit Care       Date:  2016-06-25       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.